You are here

inflammation

IGM and Sanofi collaboration will pivot to immunology and inflammation

Pharmaceutical Technology

Wed, 04/17/24 - 10:09 pm

IGM Biosciences

AbbVie Puts Potential $713M on the Line for OSE’s Inflammation Antibody

BioSpace

Wed, 02/28/24 - 11:12 am

OSE Immunotherapeutics

monoclonal antibodies

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases

Yahoo/Businesswire

Thu, 06/8/23 - 10:00 am

Inflammation space swells further as Nuvig unveils $47M to transform autoimmune therapies

Fierce Biotech

Wed, 05/11/22 - 10:30 am

protein therapeutics

Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic

Fierce Biotech

Wed, 02/9/22 - 10:07 am

Ventus Therapeutics

Arena, completing its turnaround, sells to Pfizer for nearly $7 billion

BioPharma Dive

Mon, 12/13/21 - 11:08 am

Arena Pharmaceuticals

Sanofi begins three-year immunology R&D tie-up with Stanford

Pharmaforum

Thu, 05/6/21 - 10:45 am

Galapagos reports long-awaited safety data for inflammation drug

BioPharma Dive

Thu, 03/4/21 - 11:26 pm

clinical trials

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Fierce Pharma

Mon, 10/19/20 - 10:39 am

Sanofi and Regeneron's medical congress campaign focuses on type 2 inflammation education for docs

Fierce Pharma

Tue, 11/19/19 - 11:36 pm

Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre

Xconomy

Mon, 04/1/19 - 10:31 am

anti-inflammatory

Blocking brain inflammation in multiple sclerosis with gut immune cells

Fierce Biotech

Fri, 01/4/19 - 09:08 am

multiple sclerosis

Inflazome Completes $45 Million Series B Round

CP Wire

Mon, 11/19/18 - 09:47 am

Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs

Xconomy

Thu, 11/1/18 - 12:22 pm

Denali Therapeutics

Alzheimer's disease

Sobi signs $450M deal for rare disease drug emapalumab, boosting its inflammation, I/O pipeline

Endpoints

Sat, 07/21/18 - 12:02 am

5 Ways Gilead Sciences Plans to Return to Growth

Motley Fool

Tue, 01/9/18 - 10:55 pm

Gilead Sciences

Novartis Drug May Be A New Way To Prevent Heart Attacks -- And Perhaps Cancer, Too

Forbes

Sun, 08/27/17 - 05:52 pm

Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

Forbes

Thu, 06/22/17 - 09:53 am

Pfizer anchors inflammation hopes in Xeljanz

BioPharma Dive

Wed, 10/19/16 - 06:47 pm

Amgen ends collaboration with AstraZeneca on inflammation drug

Yahoo/Reuters

Fri, 05/22/15 - 06:40 pm

Pages